What is he best known for?
The fields of study he is best known for:
- Bacteria
- Antibiotics
- Internal medicine
Thomas R. Fritsche mostly deals with Microbiology, Antibacterial agent, Antimicrobial, Acanthamoeba and Imipenem.
Microbiology and Staphylococcus aureus are frequently intertwined in his study.
His biological study spans a wide range of topics, including Enterococcus faecalis and Cephalosporin.
His work investigates the relationship between Antimicrobial and topics such as Ceftaroline fosamil that intersect with problems in Gram-positive bacteria, Activity spectrum and Staphylococcal infections.
The Acanthamoeba study combines topics in areas such as Parachlamydia acanthamoebae, 16S ribosomal RNA, Bacteria and Protozoa.
His Sentry research is multidisciplinary, relying on both Corpus albicans and Virology.
His most cited work include:
- Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004) (306 citations)
- Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program (291 citations)
- Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). (173 citations)
What are the main themes of his work throughout his whole career to date?
Thomas R. Fritsche mainly focuses on Microbiology, Antimicrobial, Antibacterial agent, Broth microdilution and Staphylococcus aureus.
His research integrates issues of Vancomycin and Virology in his study of Microbiology.
His studies in Vancomycin integrate themes in fields like Enterococcus, Enterococcus faecium and Antibiotic resistance.
The various areas that Thomas R. Fritsche examines in his Antimicrobial study include Drug resistance and Intensive care medicine.
His Antibacterial agent research focuses on subjects like Tigecycline, which are linked to Pseudomonas aeruginosa.
The concepts of his Staphylococcus aureus study are interwoven with issues in Gram-positive bacteria, Potency and Cephalosporin.
He most often published in these fields:
- Microbiology (69.46%)
- Antimicrobial (24.27%)
- Antibacterial agent (22.18%)
What were the highlights of his more recent work (between 2010-2021)?
- Lyme disease (6.28%)
- Virology (15.48%)
- Immunology (8.79%)
In recent papers he was focusing on the following fields of study:
His main research concerns Lyme disease, Virology, Immunology, Microbiology and Serology.
His Lyme disease research is multidisciplinary, incorporating elements of LYME, Borrelia, Borrelia burgdorferi and Antibiotics.
His Virology study integrates concerns from other disciplines, such as Ixodes scapularis and Powassan virus.
His Immunology research incorporates elements of Anaplasmosis, Disease, Diarrhea and Anaplasma.
A large part of his Microbiology studies is devoted to Antibiotic resistance.
As part of one scientific family, Thomas R. Fritsche deals mainly with the area of Serology, narrowing it down to issues related to the Anaplasma phagocytophilum, and often Ehrlichia.
Between 2010 and 2021, his most popular works were:
- Evidence of Multiple Virulence Subtypes in Nosocomial and Community-Associated MRSA Genotypes in Companion Animals from the Upper Midwestern and Northeastern United States (58 citations)
- Human Infection with Ehrlichia muris-like Pathogen, United States, 2007-2013(1). (37 citations)
- High diversity of plasmids harbouring blaCMY-2 among clinical Escherichia coli isolates from humans and companion animals in the upper Midwestern USA (34 citations)
In his most recent research, the most cited papers focused on:
- Bacteria
- Antibiotics
- Internal medicine
His scientific interests lie mostly in Microbiology, Serology, Internal medicine, Polymerase chain reaction and Multilocus sequence typing.
Colonization is the focus of his Microbiology research.
His study in Serology is interdisciplinary in nature, drawing from both Anaplasma phagocytophilum, Anaplasmataceae and Virology.
His Virology research integrates issues from Ixodes scapularis, Pathogen and Ehrlichia muris.
Thomas R. Fritsche has researched Polymerase chain reaction in several fields, including Plasmid, Replicon, Typing and Escherichia coli.
Within one scientific family, Thomas R. Fritsche focuses on topics pertaining to Pulsed-field gel electrophoresis under Multilocus sequence typing, and may sometimes address concerns connected to Staphylococcal infections, Staphylococcus aureus and Enterotoxin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
